Atlas Trials

Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer

Clinical trial NCT03310632 · COMPLETED

Trial details

NCT number
NCT03310632
Sponsor
Golden Biotechnology Corporation
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Neoplasm
Start date
2017-12-01
Primary completion
2023-12-30
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.